Apyx Medical Corporation (APYX)
NASDAQ: APYX · Real-Time Price · USD
1.260
-0.030 (-2.33%)
Nov 15, 2024, 4:00 PM EST - Market closed
Apyx Medical Stock Forecast
Stock Price Forecast
There is currently no analyst price target forecast available for Apyx Medical.
Analyst Consensus: Hold
Analyst Ratings
The average analyst rating for Apyx Medical stock from 2 stock analysts is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
Rating | Jun '24 | Jul '24 | Aug '24 | Sep '24 | Oct '24 | Nov '24 |
---|---|---|---|---|---|---|
Strong Buy | 1 | 1 | 1 | 0 | 0 | 0 |
Buy | 2 | 2 | 2 | 1 | 1 | 0 |
Hold | 1 | 1 | 1 | 1 | 2 | 2 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 4 | 4 | 4 | 2 | 3 | 2 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
BTIG | BTIG | Hold Initiates n/a | Hold | Initiates | n/a | n/a | Oct 17, 2024 |
JMP Securities | JMP Securities | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Sep 16, 2024 |
Stephens & Co. | Stephens & Co. | Buy Maintains $8 → $5 | Buy | Maintains | $8 → $5 | +296.83% | Nov 10, 2023 |
Piper Sandler | Piper Sandler | Buy Maintains $4 → $4.5 | Buy | Maintains | $4 → $4.5 | +257.14% | Aug 11, 2023 |
Stephens & Co. | Stephens & Co. | Buy Initiates $8 | Buy | Initiates | $8 | +534.92% | Jul 14, 2023 |
Financial Forecast
Revenue This Year
51.78M
from 52.35M
Decreased by -1.08%
Revenue Next Year
55.13M
from 51.78M
Increased by 6.46%
EPS This Year
-0.72
from -0.54
EPS Next Year
-0.68
from -0.72
Revenue Forecast
Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | 53.6M | 57.2M | 65.1M | ||
Avg | 51.8M | 55.1M | 62.3M | ||
Low | 49.6M | 52.4M | 59.1M |
Revenue Growth
Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | 2.4% | 10.5% | 18.1% | ||
Avg | -1.1% | 6.5% | 13.1% | ||
Low | -5.3% | 1.3% | 7.2% |
EPS Forecast
EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | -0.72 | -0.58 | -0.54 | ||
Avg | -0.72 | -0.68 | -0.53 | ||
Low | -0.74 | -0.74 | -0.52 |
EPS Growth
EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | - | - | - | ||
Avg | - | - | - | ||
Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.